Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com

Analysts at StockNews.com started coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report issued on Thursday. The brokerage set a “hold” rating on the medical research company’s stock.

Enzo Biochem Price Performance

Shares of Enzo Biochem stock opened at $0.49 on Thursday. Enzo Biochem has a 52 week low of $0.41 and a 52 week high of $1.38. The stock has a 50 day moving average price of $0.63 and a two-hundred day moving average price of $0.93.

Enzo Biochem (NYSE:ENZ) last announced its quarterly earnings data on Monday, December 16th. The medical research company reported ($0.05) EPS for the quarter. Enzo Biochem had a negative net margin of 75.34% and a negative return on equity of 7.96%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the stock. Mink Brook Asset Management LLC bought a new position in shares of Enzo Biochem in the fourth quarter valued at approximately $577,000. Wittenberg Investment Management Inc. lifted its holdings in shares of Enzo Biochem by 60.1% in the fourth quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock valued at $134,000 after purchasing an additional 70,400 shares in the last quarter. Virtu Financial LLC bought a new position in shares of Enzo Biochem in the fourth quarter valued at approximately $35,000. Lepercq Multi Asset Fund bought a new position in shares of Enzo Biochem in the fourth quarter valued at approximately $88,000. Finally, Geode Capital Management LLC lifted its holdings in shares of Enzo Biochem by 3.3% in the third quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after purchasing an additional 11,742 shares in the last quarter. Institutional investors own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.